MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…

MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…

Multiple myeloma (MM) affects plasma cells, a cell population within the immune system. Immunity in patients with MM is impaired due to a combination of disease-, patient-, and treatment-related factors, including age and B-cell dysfunction (leading to hypogammaglobulinemia).1, 2 Therefore, patients with MM tend to be more susceptible to vaccine-preventable infections, including influenza and…